HighTower Advisors’s TetraLogic Pharmaceuticals TLOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-27,870
Closed -$5K – 2102
2016
Q3
$5K Hold
27,870
– – ﹤0.01% 1864
2016
Q2
$8K Hold
27,870
– – ﹤0.01% 1724
2016
Q1
$5K Sell
27,870
-5,000
-15% -$1.39K ﹤0.01% 2053
2015
Q4
$57K Sell
32,870
-28,644
-47% -$50.5K ﹤0.01% 1887
2015
Q3
$114K Hold
61,514
– – ﹤0.01% 1724
2015
Q2
$144K Hold
61,514
– – ﹤0.01% 1400
2015
Q1
$269K Hold
61,514
– – ﹤0.01% 1293
2014
Q4
$296K Sell
61,514
-5,000
-8% -$22.4K ﹤0.01% 1233
2014
Q3
$277K Hold
66,514
– – ﹤0.01% 1236
2014
Q2
$392K Hold
66,514
– – 0.01% 1141
2014
Q1
$424K Buy
+66,514
New +$600K 0.01% 1041

Other funds holding TLOG

HighTower Advisors's TLOG Position: Q4 2016 in Review

HighTower Advisors sold out of TetraLogic Pharmaceuticals (TLOG) in Q4 2016, closing a stake of 27,870 shares — an estimated $5K sold.

HighTower Advisors first reported a position in TLOG in Q1 2014 and held it in 11 quarters. The position peaked at $424K in Q1 2014. 3 funds tracked by Wall St. Rank hold TLOG as of Q4 2016.

  • HighTower Advisors reported no remaining TetraLogic Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • HighTower Advisors sold 27,870 TetraLogic Pharmaceuticals shares in Q4 2016, an estimated $5K.
  • HighTower Advisors first reported a position in TetraLogic Pharmaceuticals in Q1 2014 and held it in 11 quarters.
  • HighTower Advisors's TetraLogic Pharmaceuticals position peaked at $424K in Q1 2014.
  • 3 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals as of Q4 2016.

Based on HighTower Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.